Business Wire
BusinessFTC issues civil subpoenas to OpenAI and Anthropic in consumer-protection probe, spotlighting regulatory risk for Microsoft and other major AI backersThe Apex TimesBusinessSkydance steadies after merger-era drop, Disney firms and Netflix eases lower in afternoon tradingThe Apex TimesBusinessBlackRock files a bitcoin ETF structure aimed at limiting losses and capping gains using optionsThe Apex TimesBusinessModerna shares jump 7% as melanoma vaccine data in Madrid draws attention; Bristol Myers and Pfizer also edge higherThe Apex TimesBusinessChevron seeks stake shift in Iraq oil field tied to Russian influence, as U.S. pressures the status quoThe Apex TimesBusinessCaterpillar vs. Deere in the data-center buildout debate: what investors are weighingThe Apex TimesBusinessBraze shares surge after Salesforce agrees to buy the marketing software company for $47The Apex TimesBusinessAlaska Airlines names CVS Health executive for newly created technology and AI roleThe Apex TimesBusinessEli Lilly’s pediatric ulcerative colitis trial results put Omvoh back in focus for investors, but full details remain limitedThe Apex TimesBusinessGeneral Motors shares fall about 6% even after a reported earnings beat, as investors focus on the narrower outlook rangeThe Apex TimesBusinessWalmart ties Walmart+ and Sam’s Club into a single $120-a-year membership bundleThe Apex TimesBusinessBoeing and Microsoft collaboration on an AI “dataliner” platform draws analyst attention, lifting BMO’s Microsoft targetThe Apex TimesBusinessFTC issues civil subpoenas to OpenAI and Anthropic in consumer-protection probe, spotlighting regulatory risk for Microsoft and other major AI backersThe Apex TimesBusinessSkydance steadies after merger-era drop, Disney firms and Netflix eases lower in afternoon tradingThe Apex TimesBusinessBlackRock files a bitcoin ETF structure aimed at limiting losses and capping gains using optionsThe Apex TimesBusinessModerna shares jump 7% as melanoma vaccine data in Madrid draws attention; Bristol Myers and Pfizer also edge higherThe Apex TimesBusinessChevron seeks stake shift in Iraq oil field tied to Russian influence, as U.S. pressures the status quoThe Apex TimesBusinessCaterpillar vs. Deere in the data-center buildout debate: what investors are weighingThe Apex TimesBusinessBraze shares surge after Salesforce agrees to buy the marketing software company for $47The Apex TimesBusinessAlaska Airlines names CVS Health executive for newly created technology and AI roleThe Apex TimesBusinessEli Lilly’s pediatric ulcerative colitis trial results put Omvoh back in focus for investors, but full details remain limitedThe Apex TimesBusinessGeneral Motors shares fall about 6% even after a reported earnings beat, as investors focus on the narrower outlook rangeThe Apex TimesBusinessWalmart ties Walmart+ and Sam’s Club into a single $120-a-year membership bundleThe Apex TimesBusinessBoeing and Microsoft collaboration on an AI “dataliner” platform draws analyst attention, lifting BMO’s Microsoft targetThe Apex TimesBusinessFTC issues civil subpoenas to OpenAI and Anthropic in consumer-protection probe, spotlighting regulatory risk for Microsoft and other major AI backersThe Apex TimesBusinessSkydance steadies after merger-era drop, Disney firms and Netflix eases lower in afternoon tradingThe Apex TimesBusinessBlackRock files a bitcoin ETF structure aimed at limiting losses and capping gains using optionsThe Apex TimesBusinessModerna shares jump 7% as melanoma vaccine data in Madrid draws attention; Bristol Myers and Pfizer also edge higherThe Apex TimesBusinessChevron seeks stake shift in Iraq oil field tied to Russian influence, as U.S. pressures the status quoThe Apex TimesBusinessCaterpillar vs. Deere in the data-center buildout debate: what investors are weighingThe Apex TimesBusinessBraze shares surge after Salesforce agrees to buy the marketing software company for $47The Apex TimesBusinessAlaska Airlines names CVS Health executive for newly created technology and AI roleThe Apex TimesBusinessEli Lilly’s pediatric ulcerative colitis trial results put Omvoh back in focus for investors, but full details remain limitedThe Apex TimesBusinessGeneral Motors shares fall about 6% even after a reported earnings beat, as investors focus on the narrower outlook rangeThe Apex TimesBusinessWalmart ties Walmart+ and Sam’s Club into a single $120-a-year membership bundleThe Apex TimesBusinessBoeing and Microsoft collaboration on an AI “dataliner” platform draws analyst attention, lifting BMO’s Microsoft targetThe Apex TimesBusinessFTC issues civil subpoenas to OpenAI and Anthropic in consumer-protection probe, spotlighting regulatory risk for Microsoft and other major AI backersThe Apex TimesBusinessSkydance steadies after merger-era drop, Disney firms and Netflix eases lower in afternoon tradingThe Apex TimesBusinessBlackRock files a bitcoin ETF structure aimed at limiting losses and capping gains using optionsThe Apex TimesBusinessModerna shares jump 7% as melanoma vaccine data in Madrid draws attention; Bristol Myers and Pfizer also edge higherThe Apex TimesBusinessChevron seeks stake shift in Iraq oil field tied to Russian influence, as U.S. pressures the status quoThe Apex TimesBusinessCaterpillar vs. Deere in the data-center buildout debate: what investors are weighingThe Apex TimesBusinessBraze shares surge after Salesforce agrees to buy the marketing software company for $47The Apex TimesBusinessAlaska Airlines names CVS Health executive for newly created technology and AI roleThe Apex TimesBusinessEli Lilly’s pediatric ulcerative colitis trial results put Omvoh back in focus for investors, but full details remain limitedThe Apex TimesBusinessGeneral Motors shares fall about 6% even after a reported earnings beat, as investors focus on the narrower outlook rangeThe Apex TimesBusinessWalmart ties Walmart+ and Sam’s Club into a single $120-a-year membership bundleThe Apex TimesBusinessBoeing and Microsoft collaboration on an AI “dataliner” platform draws analyst attention, lifting BMO’s Microsoft targetThe Apex Times
Back to front
Boeing shares remain far below their 2019 peak as investors debate what the “right” yardstick is
The Apex Times

THE APEX TIMES

Business/The Apex Times/Oct 20, 1:14 PM EDT

Boeing shares remain far below their 2019 peak as investors debate what the “right” yardstick is

A Trefis analysis cited by Yahoo Finance highlights how Boeing’s stock, now 56.6% below a March 2019 closing high, can look permanently “cheap” or persistently “unfixed,” depending on which benchmark investors choose.

Boeing’s stock has been trading at levels that, by one recent market framework, undershoot its March 2019 peak by a wide margin. The comparison matters because it can shape investor expectations, not just the stock’s day-to-day price action.

In the analysis distributed by Yahoo Finance, Trefis frames the question as whether investors should keep “waiting for Boeing stock to come back” by measuring the shares against where they were when Boeing appeared to be on a very different trajectory. The piece notes that Boeing shares were 56.6% below the high it closed at in March 2019 as of Oct. 20, 2026.

That kind of yardstick debate goes beyond sentiment. A long drawdown relative to an earlier closing high can reflect multiple forces at once, including company-specific execution issues, industry conditions, and investor reassessments of risk and future earnings. But it can also create an anchoring effect, where every subsequent rebound is evaluated against a single historical reference point rather than a forward view of cash flow and delivery performance.

The Trefis/Yahoo presentation does not, in the information provided here, spell out any new Boeing operational guidance or quantify an updated valuation model. Instead, the core point is methodological: if investors insist on comparing the current share price to where Boeing “belongs” relative to the March 2019 close, then rallies may look like incremental progress rather than a full reset, even when the market has already repriced the company.

For context, Boeing operates in a defense and commercial aerospace ecosystem where large, long-cycle programs and certification timelines can make investor narratives more path-dependent. In such a business, stock pricing often reflects not only reported results, but also the credibility of recovery plans, the stability of delivery schedules, and the pace at which aircraft systems regain confidence with regulators and customers.

Still, the available materials do not provide enough detail to say whether Boeing has disclosed any specific plan in the period leading up to the article that would directly justify the comparison to March 2019. The attached Boeing media relations newsroom link can provide the official record of company statements, but no individual press release or filing content is included in the material here to connect the stock move to a particular event.

Investors and analysts will likely continue to differ on what “normal” looks like for Boeing. Some will argue for benchmarking against prior highs as a proxy for what the market previously priced. Others may prefer a comparison to current fundamentals, including program risk, backlog quality, and the timing of cash generation, rather than returning to a pre-disruption reference point.

What to watch next is whether Boeing’s disclosures and reported performance can close the gap between historical expectations and forward operating reality, and whether the market shifts away from a purely historical anchor toward an outlook-driven valuation. If Boeing’s investor communication offers clearer milestones, investors may reassess whether the stock’s distance from 2019 remains the central question. Otherwise, the debate may remain largely about measurement and patience rather than fresh, verifiable progress.

Why It Matters

  • Benchmark choice can influence investor psychology, making rebounds feel incomplete or suggesting prolonged undervaluation.
  • A wide gap versus a prior peak can keep the stock vulnerable to narrative shifts, even when quarterly results stabilize.
  • If investors treat historical highs as the yardstick, it can prolong debates about whether recovery is “enough,” not just whether it is happening.
  • Without clearly tied company disclosures in the cited material, market reaction may rely more on interpretation than on new facts.

Sources

Key Facts

  • The Trefis analysis highlighted by Yahoo Finance said Boeing shares were 56.6% below the high they closed at in March 2019, as of Oct. 20, 2026.
  • The article’s framing focused on whether investors should keep waiting for Boeing stock to “come back.”
  • The central issue presented was how performance looks depending on the benchmark, specifically using the March 2019 closing high as a reference point.
  • The materials provided do not include additional Boeing operational updates or newly disclosed financial guidance tied to the comparison.

Defense Related

Oct 20, 12:14 PM EDT
The Apex Times

Northrop Grumman’s Q3 earnings call highlighted growth and backlog, while sidestepping several specifics

In remarks carried by market media on its third-quarter earnings call, Northrop Grumman said it saw sales growth across all four business segments, pointed to a record backlog, and raised its outlook, framing demand around strategic deterrence. Investors seeking more granular detail on timing and contract mix were left without answers in the cited discussion.

Northrop Grumman’s Q3 earnings call highlighted growth and backlog, while sidestepping several specifics
The Apex Times
Oct 20, 10:44 AM EDT
The Apex Times

RTX faces 2027 Pentagon sourcing rules aimed at rare-earth magnets

A new Pentagon policy beginning in January 2027 would require rare-earth magnets used in U.S. defense systems to be free of Chinese-origin materials, creating a new compliance and supplier challenge for RTX and its magnet-dependent subcontractors.

RTX faces 2027 Pentagon sourcing rules aimed at rare-earth magnets
The Apex Times
Boeing shares remain far below their 2019 peak as investors debate what the “right” yardstick is | The Apex Times